Redo mitral valve replacement in children

Kirk R. Kanter, Joseph M. Forbess, Paul M. Kirshbom

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background. Despite excellent results with current techniques of mitral valve repair, some children still require mitral valve replacement (MVR). Of necessity, a certain percentage of these children need valve rereplacement (redo MVR). Methods. Of 82 MVRs at our institution since 1988, 22 were redo MVRs in 21 children aged 1.4-21 years (mean 9.8 ± 5.6 years). Interval from initial MVR was 1 month to 18 years (mean 5.8 ± 4.9 years). Reoperation indication was primarily stenosis in 13 (usually pannus formation), regurgitation in 4, valve thrombosis or embolism in 4, and endocarditis in 1. The initial valve was mechanical in 18 and xenograft in 4. Results. During redo MVR, 8 of 22 (36%) patients had additional procedures including left ventricular outflow tract obstruction relief or aortic valve replacement in 4 and tricuspid valve repair in 2. The new mitral valve was mechanical in 20 and xenograft in 2. Median valve size increased from 21 mm to 25 mm although 7 valves were not upsized on rereplacement (average valve size increase was 3.3 ± 1 mm). Only 2 patients (9%) needed a new pacemaker. There were no hospital deaths. Six children developed end-stage heart failure and underwent successful cardiac transplantation 3 to 32 (mean 12.1 ± 10.0) months, postoperatively. On follow-up of 1 month to 7.7 years (mean 2.5 ± 2.3 years) there has been only one late death of an unrecognized coronary artery anomaly. Conclusions. Redo MVR in children can be performed safely with low morbidity and mortality. A larger prosthesis can often be placed in these children. A surprisingly high percentage of patients eventually require transplantation, perhaps reflecting unnecessary delay in referral for redo MVR.

Original languageEnglish (US)
Pages (from-to)642-646
Number of pages5
JournalAnnals of Thoracic Surgery
Volume80
Issue number2
DOIs
StatePublished - Aug 2005

Fingerprint

Mitral Valve
Heterografts
Embolism and Thrombosis
Ventricular Outflow Obstruction
Tricuspid Valve
Heart Transplantation
Endocarditis
Aortic Valve
Reoperation
Prostheses and Implants
Coronary Vessels
Pathologic Constriction
Referral and Consultation
Heart Failure
Transplantation
Morbidity
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Redo mitral valve replacement in children. / Kanter, Kirk R.; Forbess, Joseph M.; Kirshbom, Paul M.

In: Annals of Thoracic Surgery, Vol. 80, No. 2, 08.2005, p. 642-646.

Research output: Contribution to journalArticle

Kanter, Kirk R. ; Forbess, Joseph M. ; Kirshbom, Paul M. / Redo mitral valve replacement in children. In: Annals of Thoracic Surgery. 2005 ; Vol. 80, No. 2. pp. 642-646.
@article{bc9604249f23412a889883d65e68a9f6,
title = "Redo mitral valve replacement in children",
abstract = "Background. Despite excellent results with current techniques of mitral valve repair, some children still require mitral valve replacement (MVR). Of necessity, a certain percentage of these children need valve rereplacement (redo MVR). Methods. Of 82 MVRs at our institution since 1988, 22 were redo MVRs in 21 children aged 1.4-21 years (mean 9.8 ± 5.6 years). Interval from initial MVR was 1 month to 18 years (mean 5.8 ± 4.9 years). Reoperation indication was primarily stenosis in 13 (usually pannus formation), regurgitation in 4, valve thrombosis or embolism in 4, and endocarditis in 1. The initial valve was mechanical in 18 and xenograft in 4. Results. During redo MVR, 8 of 22 (36{\%}) patients had additional procedures including left ventricular outflow tract obstruction relief or aortic valve replacement in 4 and tricuspid valve repair in 2. The new mitral valve was mechanical in 20 and xenograft in 2. Median valve size increased from 21 mm to 25 mm although 7 valves were not upsized on rereplacement (average valve size increase was 3.3 ± 1 mm). Only 2 patients (9{\%}) needed a new pacemaker. There were no hospital deaths. Six children developed end-stage heart failure and underwent successful cardiac transplantation 3 to 32 (mean 12.1 ± 10.0) months, postoperatively. On follow-up of 1 month to 7.7 years (mean 2.5 ± 2.3 years) there has been only one late death of an unrecognized coronary artery anomaly. Conclusions. Redo MVR in children can be performed safely with low morbidity and mortality. A larger prosthesis can often be placed in these children. A surprisingly high percentage of patients eventually require transplantation, perhaps reflecting unnecessary delay in referral for redo MVR.",
author = "Kanter, {Kirk R.} and Forbess, {Joseph M.} and Kirshbom, {Paul M.}",
year = "2005",
month = "8",
doi = "10.1016/j.athoracsur.2005.02.052",
language = "English (US)",
volume = "80",
pages = "642--646",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Redo mitral valve replacement in children

AU - Kanter, Kirk R.

AU - Forbess, Joseph M.

AU - Kirshbom, Paul M.

PY - 2005/8

Y1 - 2005/8

N2 - Background. Despite excellent results with current techniques of mitral valve repair, some children still require mitral valve replacement (MVR). Of necessity, a certain percentage of these children need valve rereplacement (redo MVR). Methods. Of 82 MVRs at our institution since 1988, 22 were redo MVRs in 21 children aged 1.4-21 years (mean 9.8 ± 5.6 years). Interval from initial MVR was 1 month to 18 years (mean 5.8 ± 4.9 years). Reoperation indication was primarily stenosis in 13 (usually pannus formation), regurgitation in 4, valve thrombosis or embolism in 4, and endocarditis in 1. The initial valve was mechanical in 18 and xenograft in 4. Results. During redo MVR, 8 of 22 (36%) patients had additional procedures including left ventricular outflow tract obstruction relief or aortic valve replacement in 4 and tricuspid valve repair in 2. The new mitral valve was mechanical in 20 and xenograft in 2. Median valve size increased from 21 mm to 25 mm although 7 valves were not upsized on rereplacement (average valve size increase was 3.3 ± 1 mm). Only 2 patients (9%) needed a new pacemaker. There were no hospital deaths. Six children developed end-stage heart failure and underwent successful cardiac transplantation 3 to 32 (mean 12.1 ± 10.0) months, postoperatively. On follow-up of 1 month to 7.7 years (mean 2.5 ± 2.3 years) there has been only one late death of an unrecognized coronary artery anomaly. Conclusions. Redo MVR in children can be performed safely with low morbidity and mortality. A larger prosthesis can often be placed in these children. A surprisingly high percentage of patients eventually require transplantation, perhaps reflecting unnecessary delay in referral for redo MVR.

AB - Background. Despite excellent results with current techniques of mitral valve repair, some children still require mitral valve replacement (MVR). Of necessity, a certain percentage of these children need valve rereplacement (redo MVR). Methods. Of 82 MVRs at our institution since 1988, 22 were redo MVRs in 21 children aged 1.4-21 years (mean 9.8 ± 5.6 years). Interval from initial MVR was 1 month to 18 years (mean 5.8 ± 4.9 years). Reoperation indication was primarily stenosis in 13 (usually pannus formation), regurgitation in 4, valve thrombosis or embolism in 4, and endocarditis in 1. The initial valve was mechanical in 18 and xenograft in 4. Results. During redo MVR, 8 of 22 (36%) patients had additional procedures including left ventricular outflow tract obstruction relief or aortic valve replacement in 4 and tricuspid valve repair in 2. The new mitral valve was mechanical in 20 and xenograft in 2. Median valve size increased from 21 mm to 25 mm although 7 valves were not upsized on rereplacement (average valve size increase was 3.3 ± 1 mm). Only 2 patients (9%) needed a new pacemaker. There were no hospital deaths. Six children developed end-stage heart failure and underwent successful cardiac transplantation 3 to 32 (mean 12.1 ± 10.0) months, postoperatively. On follow-up of 1 month to 7.7 years (mean 2.5 ± 2.3 years) there has been only one late death of an unrecognized coronary artery anomaly. Conclusions. Redo MVR in children can be performed safely with low morbidity and mortality. A larger prosthesis can often be placed in these children. A surprisingly high percentage of patients eventually require transplantation, perhaps reflecting unnecessary delay in referral for redo MVR.

UR - http://www.scopus.com/inward/record.url?scp=22544457883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22544457883&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2005.02.052

DO - 10.1016/j.athoracsur.2005.02.052

M3 - Article

C2 - 16039220

AN - SCOPUS:22544457883

VL - 80

SP - 642

EP - 646

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 2

ER -